Hannover Re Taps Neurotrack to Offer Digital Brain Health Assessments

Hannover Re Taps Neurotrack to Offer Digital Brain Health AssessmentsHannover Re Taps Neurotrack to Offer Digital Brain Health Assessments

What You Should Know:

– Neurotrack today shows how life insurers are now taking
brain health seriously, as Hannover Re, one of the world’s largest reinsurers,
becomes one of the first life insurance companies to offer digital brain health
assessments.

– The partnership between Neurotrack and Hannover Re US
is the first of its kind in the United States, following Neurotrack’s
successful rollout with Japanese life insurers SOMPO Himawari Life and Dai-ichi
Life, which offer Neurotrack’s digital cognitive assessment to policyholders as
part of their new dementia insurance offering.


As populations continue to age globally, life insurance
companies and their customers have been increasingly affected by the rising
numbers of Alzheimer’s disease. To prepare for future aging populations and how
to best serve them, insurers are investing for the first time in digital
assessment technologies that will enable policyholders to manage and track
their cognitive health. An announcement today by Neurotrack, a digital
health company, and Hannover
Life Reassurance Company of America
 (Hannover Re US), a member of
Hannover Re Group, the third largest reinsurance group in the world, signals
how the industry is turning to digital technology to benefit insurers and
policyholders by changing the future of aging. 

Bringing Brain Health to Life Insurance

Neurotrack is announcing a partnership with Hannover Re US
to offer Neurotrack’s clinically-validated cognitive health program to the life
insurance market for use by their policyholders. The partnership between
Neurotrack and Hannover Re US is the first of its kind in the United States,
following Neurotrack’s successful rollout with Japanese life insurers SOMPO Himawari Life and Dai-ichi Life,
which offer Neurotrack’s digital cognitive assessment to policyholders as part
of their new dementia insurance offering.

Neurotrack’s Cognitive Health Program Background

The commercialization of Neurotrack’s cognitive health program has been in place since 2018 in Japan, which, as the oldest average-age population in the industrialized world, has the highest rate of Alzheimer’s cases and is facing the challenge of caring for a nation of “superagers.” The results of early detection and intervention there were documented in a 2019 pilot. Those results have now been expanded with new data. Early findings show that the highest rate of participation in Neurotrack’s digital cognitive assessment was with policyholders in their 40s, decades younger than the average age of people with Alzheimer’s. In fact, more policyholders ages 20-49 took Neurotrack’s “brain check-up” than did policyholders ages 50 and older. The data suggests that given an accessible and accurate method of testing, younger people are keenly interested in understanding and maintaining their cognitive health.

“Hannover Re has officially collaborated with Neurotrack, who has spent the last eight years solving one of the more pressing hurdles in insurance: how to accurately administer a cognitive assessment and help individuals monitor and manage their cognitive health,” said Kevin Oldani, SVP and chief underwriter, Hannover Re US. “In a world that has become almost entirely digital, insurance underwriting still heavily relies on paper and pencil processes that take the average applicant 12 weeks to apply. Insurance companies that are dynamic enough to improve their customer experience by digitizing assessments that streamline the underwriting process will ultimately win.”

 Why It Matters

The announcement — coinciding with World Alzheimer’s Day —
supports the insurance industry’s movement towards serving the whole person —
from heart disease and diabetes prevention to stress management, and, now,
cognitive health. Early assessment, detection and lifestyle interventions have
reduced the risk of Alzheimer’s for patients by as much as 33% in numerous
studies, beginning with the groundbreaking FINGER study in
2015 and now being further developed in multiple world-wide studies. An August
2020 report in the Lancetidentifies the 12 modifiable risk factors that could
be addressed to reduce the incidence of Alzheimer’s by 40%.

The advances of digital assessment enable individuals to
test themselves regularly from home, monitoring their cognitive health over
time. Insurers, who are often relied upon in some of the most difficult moments
of life, can now offer a valuable digital resource to deepen and expand those
relationships, becoming active partners in maintaining their policyholders’
cognitive health.

“Until recently, the idea of preventing dementia wasn’t widely understood as a possibility, and the rising incidence in Japan has become a situation of national concern,” said Yuko Nakagawa, executive officer and general manager of Business Planning at SOMPO Himawari Life. “We established ‘Insurhealth’ to integrate insurance and health services. Since the partnership with Neurotrack began in 2018, we have been introducing their technology to our dementia insurance policyholders to help them become more active in assessing and strengthening their cognitive health. The engagement from younger policyholders has been impressive and supports our mission to use this innovative approach to reduce dementia in Japan, improving the health of the population and decreasing the costs caused by the illness.” 

<!–

–>